Amyloid-β–Associated Clinical Decline Occurs Only in the Presence of Elevated P-tau
Rahul S. Desikan(Boston University), for the Alzheimer’s Disease Neuroimaging Initiative, Linda K. McEvoy(MACOM (United States)), Anders M. Dale(J. Craig Venter Institute), Wesley K. Thompson(Sankt Hans Hospital), Paul Aisen(University of Southern California), Reisa A. Sperling(Harvard University), James B. Brewer(University of California San Diego), Dominic Holland(University of San Diego)
Cited by 139
Related Papers
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
|NeuroImage|2006|14.1k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k